Wakefield Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.51M	Buy	+41,349	New	+$2.41M	0.66%	44
2025 Q1	–	Sell	-60,226	Closed	-$3.41M	–	201
2024 Q4	$3.41M	Buy	+60,226	New	+$3.37M	1.15%	31
2023 Q1	–	Sell	-4,439	Closed	-$319K	–	161
2022 Q4	$319K	Buy	+4,439	New	+$335K	0.14%	146
2021 Q2	–	Sell	-39,379	Closed	-$2.49M	–	157
2021 Q1	$2.49M	Buy	39,379 +2,187	+6%	+$136K	1%	28
2020 Q4	$2.31M	Sell	37,192 -2,382	-6%	-$146K	0.97%	35
2020 Q3	$2.39M	Sell	39,574 -203	-0.5%	-$12.2K	1.12%	30
2020 Q2	$2.34M	Sell	39,777 -7,856	-16%	-$470K	1.12%	26
2020 Q1	$2.65M	Buy	47,633 +2,640	+6%	+$161K	1.43%	11
2019 Q4	$2.89M	Sell	44,993 -4,195	-9%	-$240K	1.2%	14
2019 Q3	$2.49M	Sell	49,188 -16,236	-25%	-$763K	1.09%	35
2019 Q2	$2.97M	Sell	65,424 -8,109	-11%	-$378K	1.17%	34
2019 Q1	$3.51M	Buy	73,533 +5,056	+7%	+$252K	1.27%	26
2018 Q4	$3.56M	Buy	+68,477	New	+$3.68M	1.54%	11